KERRI LISKA: Open Payments
NPI 1508312562 · NORTH FALMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,547 in 158 payments from 14 companies in 2025. Trend: 2023 $2,687 · 2024 $2,711 · 2025 $2,547
Food & beverage: $2,537Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 75 | $564 |
| Janssen Biotech, Inc. | 30 | $519 |
| UCB, Inc. | 9 | $264 |
| GENZYME CORPORATION | 8 | $262 |
| E.R. Squibb & Sons, L.L.C. | 9 | $198 |
| Novartis Pharmaceuticals Corporation | 6 | $173 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $135 |
| Regeneron Healthcare Solutions, Inc. | 3 | $93 |
| LEO Pharma Inc. | 3 | $83 |
| Amgen Inc. | 3 | $77 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Bimzelx, Sotyktu, RINVOQ, ILUMYA, Otezla.
Industry payments across MA — which companies pay providers there.
